Making Breast Tumors Tamoxifen-Sensitive

    Cancer Discovery
    |March 30, 2018
    PubMed

    Insights

    Disrupting platelet-derived growth factor signaling may transform basal-like breast tumors into a subtype responsive to antiestrogen therapies. This offers a novel treatment strategy for difficult-to-treat breast cancers.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Cancer Research

    Background:

    • Basal-like breast tumors represent an aggressive subtype often lacking effective targeted therapies.
    • Platelet-derived growth factor (PDGF) signaling is implicated in various cancer progressions.
    • Tumor subtype plasticity is a critical factor in treatment resistance.

    Discussion:

    • This study investigates the potential of targeting platelet-derived growth factor (PDGF) signaling as a therapeutic strategy for basal-like breast cancer.
    • Researchers explored methods to disrupt PDGF signaling, including genetic manipulation and antibody-based blockade.
    • The study observed a phenotypic switch in basal-like tumors towards the luminal subtype upon PDGF pathway inhibition.

    Key Insights:

    • Disrupting PDGF signaling can induce a transition from basal-like to luminal breast tumor subtypes.
    • The luminal subtype is known to be sensitive to established antiestrogen therapies.
    • This subtype plasticity presents a promising avenue for treating previously resistant breast cancers.

    Outlook:

    • Further research is warranted to validate these findings in clinical settings.
    • This strategy could potentially overcome resistance to current breast cancer treatments.
    • Targeting PDGF signaling may offer a new therapeutic paradigm for basal-like breast cancer patients.

    Related Concept Videos

    Sensitivity, Specificity, and Predicted Value01:13

    Sensitivity, Specificity, and Predicted Value

    In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
    Sensitivity is the...
    1.4K
    Sputum Studies II: Culture and Sensitivity01:20

    Sputum Studies II: Culture and Sensitivity

    Description
    Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
    The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
    1.3K
    Urine Studies II: Urine Culture and Sensitivity Test01:26

    Urine Studies II: Urine Culture and Sensitivity Test

    A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
    1.3K
    Tumor Immunotherapy01:27

    Tumor Immunotherapy

    Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
    2.0K
    Tumor Progression02:07

    Tumor Progression

    Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
    Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
    7.5K
    The Tumor Microenvironment02:17

    The Tumor Microenvironment

    Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
    7.9K